H.C. Wainwright Assumes Citius Pharmaceuticals (CTXR) at Buy, Cuts PT to $3
Tweet Send to a Friend
H.C. Wainwright analyst Vernon Bernardino assumes primary coverage form analyst Kevin Dede ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
